Pluri Inc. Long-term Debt and Lease Obligation
Pluri Inc. (PLUR) had Long-term Debt and Lease Obligation of $1.26 million as of 2020-06-30, per its 10-K filed 2020-09-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtAndCapitalLeaseObligations · last filed 2020-09-10
- 2020-06-30: Long-term Debt and Lease Obligation $1.26M.
- 2020-03-31: Long-term Debt and Lease Obligation $1.26M.
- 2019-12-31: Long-term Debt and Lease Obligation $1.26M.
- 2019-09-30: Long-term Debt and Lease Obligation $1.26M.
| Period end | Long-term Debt and Lease Obligation |
|---|---|
| 2020-06-30 | $1.26M 10-K · filed 2020-09-10 |
| 2020-03-31 | $1.26M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.26M 10-Q · filed 2020-02-06 |
| 2019-09-30 | $1.26M 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |